Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms-Reference-Cited by-同舟云学术

Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms

Published:2020-07-16 Issue:5 Volume:24 Page:579-592
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Park Joonhong^ORCID,Kim Hoon Seok^ORCID,Lee Jong-Mi^ORCID,Jung Jin^ORCID,Kang Dain^ORCID,Choi Hayoung^ORCID,Lee Gun Dong,Son Jungok,Park Silvia^ORCID,Cho Byung‐Sik^ORCID,Kim Hee‐Je^ORCID,Kim Seongkoo,Lee Jae Wook^ORCID,Chung Nack-Gyun^ORCID,Cho Bin^ORCID,Zhang Hua^ORCID,Khazanov Nickolay A.^ORCID,Choi Jongpill^ORCID,Jung Jae-Won^ORCID,Kim Yonggoo^ORCID,Kim Myungshin^ORCID

Funder

Ministry of Food and Drug Safety

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40291-020-00484-5.pdf

Reference31 articles.

1. Luthra R, Patel KP, Reddy NG, Haghshenas V, Routbort MJ, Harmon MA, et al. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring. Haematologica. 2014;99(3):465–73. https://doi.org/10.3324/haematol.2013.093765.

2. Shumilov E, Flach J, Kohlmann A, Banz Y, Bonadies N, Fiedler M, et al. Current status and trends in the diagnostics of AML and MDS. Blood Rev. 2018;32(6):508–19. https://doi.org/10.1016/j.blre.2018.04.008.

3. Bacher U, Shumilov E, Flach J, Porret N, Joncourt R, Wiedemann G, et al. Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Blood Cancer J. 2018;8(11):113. https://doi.org/10.1038/s41408-018-0148-6.